English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Medicameq Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Medicamen Biotech

    Small Cap
    ₹454.65
    +15.65 (3.56%)
    29 June, 2024 03:41 BSE: 531146 NSE: MEDICAMEQISIN: INE646B01010

    Start SIP in Medicamen Biotech

    Start SIP

    Medicamen Biotech Performance

    Day Range

    • Low 440
    • High 483
    ₹ 454

    52 Week Range

    • Low 355
    • High 845
    ₹ 454
    • Open Price443
    • Previous Close439
    • Volume62147

    Medicamen Biotech Share Price

    • Over 1 Month -13.18%
    • Over 3 Month +18.83%
    • Over 6 Month -21.93%
    • Over 1 Year -35.24%

    Medicamen Biotech Key Statistics

    P/E Ratio 60.3
    PEG Ratio -1.7
    Market Cap Cr 578
    Price to Book Ratio 2.9
    EPS 10.5
    Dividend 0.2
    Relative Strength Index 42.02
    Money Flow Index 36.08
    MACD Signal -6.89
    Average True Range 24.36
    Medicamen Biotech Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 4544434137
    Operating Expenses Qtr Cr 3839373330
    Operating Profit Qtr Cr 76677
    Depreciation Qtr Cr 22222
    Interest Qtr Cr 21111
    Tax Qtr Cr 11111
    Net Profit Qtr Cr 33344
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 175140
    Operating Expenses Annual Cr 146114
    Operating Profit Annual in Cr 2624
    Depreciation Cr 76
    Interest Annual Cr 43
    Tax Annual Cr 42
    Net Profit Annual Cr 1315
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 0-3
    Cash from Investing Activity Annual Cr -9-8
    Cash from Financing Annual Activity Cr 328
    Net Cash Flow Annual Cr 17
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 209193
    Fixed Assets Annual Cr 9192
    Total Non Current Assets Annual Cr 142119
    Total Current Assets Annual Cr 152158
    Total Assets Annual Cr 294277
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 165152
    ROE Annual % 68
    ROCE Annual % 1010
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1619
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 4747444239
    Operating Expenses Qtr Cr 4242393532
    Operating Profit Qtr Cr 65576
    Depreciation Qtr Cr 22222
    Interest Qtr Cr 21111
    Tax Qtr Cr 11111
    Net Profit Qtr Cr 22144
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 182143
    Operating Expenses Annual Cr 157117
    Operating Profit Annual in Cr 2224
    Depreciation Cr 76
    Interest Annual Cr 43
    Tax Annual Cr 42
    Net Profit Annual Cr 1115
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 0-6
    Cash from Investing Activity Annual Cr -6-6
    Cash from Financing Annual Activity Cr 029
    Net Cash Flow Annual Cr 17
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 200191
    Fixed Assets Annual Cr 9293
    Total Non Current Assets Annual Cr 135115
    Total Current Assets Annual Cr 160163
    Total Assets Annual Cr 295279
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 158151
    ROE Annual % 58
    ROCE Annual % 910
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1419
    Invest in Medicamen Biotech

    Medicamen Biotech Technicals

    EMA & SMA

    Current Price
    ₹454.65
    +15.65 (3.56%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹473.72
    • 50 Day
    • ₹481.18
    • 100 Day
    • ₹496.26
    • 200 Day
    • ₹542.92
    • 20 Day
    • ₹473.76
    • 50 Day
    • ₹490.44
    • 100 Day
    • ₹476.06
    • 200 Day
    • ₹546.39

    Medicamen Biotech Resistance and Support

    PIVOT
    ₹459.22
    Resistance
    First Resistance 478.43
    Second Resistance 502.22
    Third Resistance 521.43
    RSI 42.02
    MFI 36.08
    MACD Single Line -6.89
    MACD -10.06
    Support
    First Support 435.43
    Second Support 416.22
    Third Supoort 392.43

    Medicamen Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 71,643 2,427,981 33.89
    Week 31,930 1,570,298 49.18
    1 Month 31,702 1,339,426 42.25
    6 Month 42,851 2,211,537 51.61

    Medicamen Biotech Result Highlights

    Medicamen Biotech Synopsis

    NSE-Medical-Generic Drugs

    Medicamen Biotec is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 137.88 Cr. and Equity Capital is Rs. 12.65 Cr. for the Year ended 31/03/2023. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
    Market Cap 578
    Sales 172
    Shares in Float 0.72
    No of funds 6
    Yield 0.19
    Book Value 2.78
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha -0.24
    Beta 1.55

    Medicamen Biotech Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 43.21%43.21%43.21%43.21%
    Mutual Funds
    Foreign Portfolio Investors 0.12%0.22%0.22%0.16%
    Individual Investors 31.96%31.9%31.81%31.43%
    Others 24.71%24.67%24.76%25.2%

    Medicamen Biotech Management

    Name Designation
    Mr. Rahul Bishnoi Chairman
    Dr. Vimal Kumar Shrawat Non Executive Director
    Mr. Sanjay Bansal Non Executive Director
    Mr. Suresh Kumar Singh Non Executive Director
    Mr. Ashwani Kumar Sharma Non Executive Director
    Mr. Harish Pande Independent Director
    Ms. Sangeeta Bishnoi Independent Director
    Dr. Ravi Kumar Bansal Independent Director
    Mr. Arun Kumar Independent Director
    Ms. Sumita Dwivedi Independent Director

    Medicamen Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Medicamen Biotech Corporate Action

    Date Purpose Remarks
    2024-05-29 Audited Results & Final Dividend
    2024-02-12 Quarterly Results
    2023-11-10 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-29 Audited Results & Final Dividend

    Medicamen Biotech MF Shareholding

    Name Amount(cr)

    Medicamen Biotech FAQs

    What is Share Price of Medicamen Biotech ?

    Medicamen Biotech share price is ₹454 As on 29 June, 2024 | 03:27

    What is the Market Cap of Medicamen Biotech ?

    The Market Cap of Medicamen Biotech is ₹578.1 Cr As on 29 June, 2024 | 03:27

    What is the P/E ratio of Medicamen Biotech ?

    The P/E ratio of Medicamen Biotech is 60.3 As on 29 June, 2024 | 03:27

    What is the PB ratio of Medicamen Biotech ?

    The PB ratio of Medicamen Biotech is 2.9 As on 29 June, 2024 | 03:27

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.